|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01061 ESSEX BIO-TECH
Nominal 
3.370 +0.040 (+1.201%) Ranking Overview
Ranking based on 1 research report(s)
Average Ranking 2.00
|
Strong Buy (1)
0
|
Buy (2)
1
|
Hold (3)
0
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2025 | EPS | 56.10 HKD (cts) | |
| Net Profit | 318.09 HKD (MIL) | DPS | 14.00 HKD (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (HKD (MIL)) |
EPS/ ((LPS)(HKD (cts)) |
DPS (HKD (cts)) |
Net Asset Value per Share (HKD) |
Highest (HKD (MIL)) |
Lowest (HKD (MIL)) |
| 2026 | 320.65 | 57.00 | -- | 320.65 | 320.65 | |
| 2027 | 351.15 | 62.00 | -- | 351.15 | 351.15 | |
| 2028 | 423.45 | 74.00 | -- | 423.45 | 423.45 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (HKD (MIL)) |
EPS*/ (LPS) (HKD (cts)) |
DPS * (HKD (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2026 | 320.65 | 57.00 | -- | GUOYUAN SEC | Buy | 6.84 | 01/04/2026 | |
| 2027 | 351.15 | 62.00 | -- | GUOYUAN SEC | -- | -- | 01/04/2026 | |
| 2028 | 423.45 | 74.00 | -- | GUOYUAN SEC | -- | -- | 01/04/2026 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 15/04/2026 11:13 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 318,091 |
| %Change | 3.538% |
| EPS / (LPS) | HKD 0.561 |
| NBV Per Share ($) | HKD 4.256 |